Mingyi Zhou
China Medical University (PRC)
12 Papers
11 Citations
Mingyi Zhou is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Colorectal cancer & Stage IIIC. The author has an hindex of 5, co-authored 12 publications.
Chat about Author
Papers
The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex.
TL;DR: In this paper, the authors identified the circRNA signature of upregulated circRNAs between cervical cancer and paired adjacent normal tissues and provided the first evidence that circZFR is a novel onco-circRNA and might be a potential biomarker and therapeutic target for cervical cancer patients.
Phase III trials of standard chemotherapy with or without bevacizumab for ovarian cancer: a meta-analysis.
TL;DR: The 7.5 mg/kg dose appeared to be optimal for newly diagnosed OC patients with high risk for progression, but 15mg/kg Bev increased toxicities.
45
Efficacy of Bevacizumab in the First-Line Treatment of Patients with RAS Mutations Metastatic Colorectal Cancer: a Systematic Review and Network Meta-Analysis.
TL;DR: There was insufficient evidence to definitively state that patients with RAS mutations mCRC could benefit from bevacizumab combined with chemotherapy as first-line treatment.
Neutrophil-to-Lymphocyte Ratio and Platelet Count Predict Long-Term Outcome of Stage IIIC Epithelial Ovarian Cancer.
TL;DR: H-NLR and H-PC could predict poor long-term outcome of patients with FIGO stage III EOC, and the optimal cut-off value of 3.08 for NLR and 289.5*109/L was identified.
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients
Ping Yu,Mingyi Zhou,Jinglei Qu,Lingyu Fu,Xuedan Li,Ruimei Cai,Bo Jin,Yuee Teng,Jing Liu,Jing Shi,Jingdong Zhang +10 more
TL;DR: CEA changes mirror the tumor response to first-line chemotherapy and are associated with prognosis, so CEA monitoring may be a substitute for computed tomography during the CEA stable period of treatment.